McKesson Corporation (MCK) : Analyst Rating Update

McKesson Corporation (MCK) : 6 brokerage houses believe that McKesson Corporation (MCK) is a Strong Buy at current levels. 2 Analyst considers the fundamentals to be worthy of a Buy recommendation. 5 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on McKesson Corporation (MCK). Zacks Investment Research suggests a Buy with a rank of 2.The median of all the 13 Wall Street Analysts endorse the stock as a Buy with a rating of 1.88.

McKesson Corporation (MCK) stock is expected to deviate a maximum of $16.23 from the average target price of $192.8 for the short term period. 10 Street Experts have initiated coverage on the stock with the most promising target being $220 and the most muted being $172.

McKesson Corporation (NYSE:MCK): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $186.90 and $185.43 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $192.11. The buying momentum continued till the end and the stock did not give up its gains. It closed at $191.88, notching a gain of 2.35% for the day. The total traded volume was 2,095,594 . The stock had closed at $187.48 on the previous day.

Also, Equity analysts at the Brokerage firm Barclays terminates its rating on McKesson Corporation (NYSE:MCK). Earlier, the shares were rated a Overweight by the brokerage firm. The rating by the firm was issued on June 28, 2016. The company shares have dropped -16.50% from its 1 Year high price. On Jul 16, 2015, the shares registered one year high at $236.86 and the one year low was seen on Feb 9, 2016. The 50-Day Moving Average price is $182.25 and the 200 Day Moving Average price is recorded at $170.72.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.